2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Pocket Pal
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Michael S. Agus, MD (he/him/his)

Boston Children's Hospital, Massachusetts

Dr. Agus is the Division Chief of Medical Critical Care within the Department of Pediatrics at Boston Children’s Hospital where he was the Founding Medical Director of the Medical Intensive Care Unit (MICU) and the Pediatric Intermediate Care Unit (PIMCU). He is trained and board certified both as a pediatric endocrinologist and pediatric intensivist, and holds the Constantine Anast Professorship of Pediatrics at Harvard Medical School. He is Chair of the Governance Committee of the ICUs, Chair of the Medical Staff Credentials Committee, Co-Medical Director of the BCH Biocontainment Unit as well as the leader of several other committees and initiatives at BCH, and a leader in various national societies in Pediatric Critical Care.
Dr. Agus is a clinical trialist engaged in research activities that attempt to address unanswered questions concerning endocrine homeostasis in critically ill children, focusing on glycemic control and the use of glucocorticoids in the ICU. He completed two NHLBI/NIH R01-funded prospective, randomized clinical trials of glucose control, two of the largest RCTs in the field of pediatric critical care. The first, called SPECS involved 980 post-operative cardiac surgery patients <3 years of age at two centers. The second included 780 medical/surgical patients in 35 Pediatric ICUs across the US and Canada. Results of both trials were published in the New England Journal of Medicine. He used technology, honed over several years of research, to allow the lowest severe hypoglycemia rate in the field. He is currently one of the lead investigators of the NICHD/NIH-funded multicenter SHIPSS trial, Stress Hydrocortisone in Pediatric Septic Shock. He is part of the executive design committee of the PALISI Platform Trial. He has coauthored several international guidelines on critical care.

Presentation(s):